Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Classical hematology 1

Conditions

Anemia 4Multiple Myeloma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Solid Tumors 1Small Cell Lung Carcinoma 1Primary Myelofibrosis 1Neoplasms 1Neoplasm Metastasis 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 27Busulfan 25fludarabine phosphate 24Antilymphocyte Serum 20Tacrolimus 18Peripheral Blood Stem Cell Transplantation 18Cyclosporine 15Radiotherapy 14Mycophenolic Acid 14Methotrexate 14Melphalan 12Filgrastim 11Whole-Body Irradiation 10Methylprednisolone 10Cord Blood Stem Cell Transplantation 9Etoposide 7Cytarabine 5sargramostim 4Thiotepa 4Thalidomide 4Specimen Handling 4Sirolimus 4Rituximab 4Cyclosporins 4Biopsy 4Alemtuzumab 4ruxolitinib 3Flow Cytometry 3Arsenic Trioxide 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Myelodysplastic-Myeloproliferative Diseases × ACE-011 × Clear all
NCT01712308 2023-10-10

Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia

M.D. Anderson Cancer Center

Phase 2 Completed
56 enrolled 9 charts
Classical hematologyMyeloid

Anemia, Myelodysplastic-Myeloproliferative Diseases, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡